A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A prospective multicenter study comparing patients with CRVO amd secondary macular edema treated with ranibizumab versus sham. Safety and efficacy will be evaluated. Patients will be randomized in a 1:1 ratio to one of the two arms. 32 patients, 6 months follow up. There will be monthly visits with injection the first three months and subsequently new injection if present edema.
Epistemonikos ID: 67abc4c5fe1481e06c55b952ed0d7a09a59c3aa4
First added on: May 04, 2024